Renovaro Biosciences (RENB)
NASDAQ:RENB
Holding RENB?
Track your performance easily

Renovaro Biosciences (RENB) Income Statement

134 Followers

Renovaro Biosciences Income Statement

Last quarter (Q ), Renovaro Biosciences's total revenue was $―, a decrease of ― from the same quarter last year. In Q, Renovaro Biosciences's net income was $-44.21M. See Renovaro Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Jun 24Jun 23Jun 22Jun 21Jun 20
Total Revenue
--$ 352.70K$ 2.96K--
Cost of Revenue
----$ 13.80M-
Gross Profit
--$ 352.70K$ 2.96K$ -13.80M-
Operating Expense
$ 126.09M$ 81.64M$ 38.56M$ 22.83M$ 23.40M$ 11.92M
Operating Income
$ -126.09M$ -81.64M$ -38.56M$ -116.08M$ -23.40M$ -11.92M
Net Non Operating Interest Income Expense
$ -436.25K-$ -706.96K$ -250.80K$ -366.43K$ -53.98K
Other Income Expense
$ 44.03M$ 43.91M$ 18.96M$ -90.36M$ 3.05M$ -414.57K
Pretax Income
$ -126.98M$ -82.94M$ -38.56M$ -113.43M$ -26.85M$ -11.42M
Tax Provision
$ -24.07M$ -24.07M$ -70.34M$ 34.00$ -125.28K$ -2.83M
Earnings From Equity Interest Net Of Tax
-----$ -274.57K
Net Income Common Stockholders
$ -115.69M$ -80.65M$ -39.68M$ -113.43M$ -26.72M$ -11.42M
Basic EPS
$ -0.98$ -0.84$ -0.71--$ -0.25
Diluted EPS
$ -0.98$ -0.84$ -0.71-$ -0.57$ -0.25
Basic Average Shares
$ 477.08M$ 96.25M$ 56.27M-$ 47.17M$ 46.33M
Diluted Average Shares
$ 477.08M$ 96.25M$ 56.27M-$ 47.17M$ 46.33M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 126.09M$ 81.64M$ 38.56M$ 22.83M$ 37.21M$ 11.92M
Net Income From Continuing And Discontinued Operation
$ -115.69M$ -80.65M$ -39.68M$ -113.43M$ -26.72M$ -11.42M
Normalized Income
$ -48.43M$ -52.76M-$ 3.64M$ -26.97M-
Interest Expense
------
EBIT
$ -139.17M$ -104.72M$ -38.98M$ -113.06M$ -26.47M$ -11.31M
EBITDA
$ -138.97M$ -104.01M$ -38.86M$ -112.94M$ -26.35M$ -10.95M
Currency in USD

Renovaro Biosciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis